Translate
About
Aeolus Pharmaceuticl (PINK:AOLS) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 23 2018
Aeolus Announces Commencement of Assignment for the Benefit of Creditors
Sep 26 2017
Aeolus Announces Presentation of Pharmacometric Analysis Confirming Statistically Significant Improvement in Survival 6 Months After Exposure to Lethal Thoracic Radiation Following Treatment with AEOL 10150
Sep 22 2017
Aeolus Announces Presentation of Pharmacometric Analysis of Data Establishing Optimal Dose Schedule of AEOL 10150 for Treatment of Lung Radiation Damage
Sep 20 2017
Aeolus Announces Publication of Data Demonstrating that Adding AEOL 10150 to Standard Therapy After Nerve Agent Exposure Improves Survival and Reduces Brain Damage and Nerve Inflammation in Rats
Sep 18 2017
AEOLUS' AEOL 10150 is Safe and Well Tolerated in Phase 1 Study in Healthy Subjects
Recent Videos
David Cavalier - Aeolus Pharmaceuticals
Oct 06, 2017
Update with Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) June 2016 | Stock News Now
Jul 06, 2016
Aeolus Pharmaceuticals
Mar 19, 2015
SNNLive - Aeolus Pharmaceuticals Inc.
Jul 31, 2014
Financials
Revenue
$771 K
Market Cap
$15.21 K
EPS
0.00